• Schedule An Appointment
  • (855) 528-7322
  • Career Openings
  • Español 中國傳統的 简体中文
  • Locations
  • Care Team
  • Locations
  • Care Team
    • All Doctors
    • Medical Oncologists
    • Radiation Oncologists
    • Breast Surgeons
    • Surgical Oncologist
    • Support/Palliative
    • Behavioral Health
    • Registered Dietitian Nutritionists
    • Our APPs
  • Patients
    • Accepted Insurance
    • Appointments
    • Blood Disorders
    • Cancers
    • Carespace Portal
    • Fill my Prescription
    • Make A Payment
    • Mammography
    • Medical Marijuana
    • Patient Advocacy
    • Physical Therapy
    • Radiology
  • Professionals
    • Patient Referral
    • Clinical Trials
    • Our Research Center
    • Our Research Team
    • Career Opportunities
    • News & Events
    • NCCN Guidelines
    • Oncology Medical Home (OMH)
  • Research
    • About Research
    • Common Questions
    • Study Participation
    • Our Research Center
    • Our Research Team
    • Clinical Trials
  • About
    • About Us
    • Events
    • News & Updates
    • Our Leadership
    • Our Difference
    • Our Friends
    • Our Services
      • Medical Oncology
      • Radiation Oncology
      • Hematology
      • Fill My Prescription
      • Physical Therapy
      • Health & Wellness
      • Laboratory Testing
      • Personalized Medicine
      • Diagnostic Imaging
      • Other Services
    • Career Opportunities
      • Opportunities
      • Request for Educational Opportunities
    • Newsletters

RADIONUCLIDE THERAPIES

Radionuclide therapies utilize radiopharmaceutical drugs that target specific types of tumors. Releasing energy, these drugs can bring radiation to tumors in targeted doses and therefore sparing normal and healthy tissues.

Radiopharmaceutical consists of a radioisotope ion bonded to an organic molecule, which in turn conveys the radioisotope to the targeted organ, tissue, or cell.  The choice of the radioisotope depends on the affinity or the binding power to the target structures of the tumor-like antigens and receptors. The radiation from the radioactive nuclide damages the DNA of the cancer cells, killing them in the process and shrinking the tumors. Radiopharmaceuticals not only effectively eliminate malignant tumor cells but also spare healthy tissues and organs.

How It Works

The ionizing radiation emitted by the radionuclide determines the biological activity of the radiopharmaceutical.  In radionuclide therapy, a different type of radionuclide is needed and far from those that emit gamma radiation that can penetrate the body. As such, radionuclides appropriate for tumor therapy are those with alpha or beta emitters as these can penetrate radiation into nearby tissues.

Radionuclide Therapies
Palliatives:
  • Xofigo
    • Xofigo is a radioactive agent used for the treatment of prostate cancer with metastatic bone disease. It is administered intravenously as a slow injection over a minute. Injections are performed monthly over the course of 6 months.
  • Quadramet
    • Quadramet is an injectable radiopharmaceutical for treating bone pain associated with various cancer types. Given as a single injection. It can be repeated if MD determines it can benefit patient relief.
Therapeutic:
  • Zevalin
    • Zevalin is a treatment for Follicular Lymphoma that combines two effective therapies in a single course of treatment: Immunotherapy and Radiotherapy. The entire treatment regimen can be completed in 7–9 days. It is administered intravenously.

Note:  We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in this website is meant to be helpful and educational but is not a substitute for medical advice.

Call Us

(855) 528-7322

Contact us today to request an appointment.

Virtual & Telemedicine available.

Request Appointment

Patient Links

  • Make An Appointment
  • Make A Payment
  • Fill My Prescription
  • Accepted Insurance
  • Medical Marijuana
  • Appointment Information
  • Physical Therapy
  • Patient Advocacy
  • Carespace Portal
  • Cancer Information

About

  • Our Story
  • Our Care Team
  • Locations
  • Careers & Job Openings
  • Newsletters
  • What Is Cancer?
  • What Are Blood Disorders?
  • What Is Oncology?
  • What Is Hematology?
  • Podcasts
  • Oncology Medical Home (OMH)

Research

  • About Research
  • Common Questions
  • Study Participation
  • Our Research Center
  • Our Research Team
  • Clinical Trials
  • Observational Studies
  • Cancer Resources
  • Blood Disorder Resources

Contact Us


info@nycancer.com

  • Terms and Conditions
  • Privacy Policy
  • HIPAA and Compliance
  • Healthix
© 2025 NYCancer.com